New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹

Go back to New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹
Zoetis (NYSE: ZTS) Delayed: 81.28 +1.66 (2.08%)
Previous Close $79.62    52 Week High $53.14 
Open $79.90    52 Week Low $38.26 
Day High $82.08    P/E 80.48 
Day Low $79.90    EPS $1.01 
Volume 1,355,545